scholarly journals Understanding Parkinson’s Disease (PD) in Ayurvedic Prospective

2021 ◽  
pp. 86-92
Author(s):  
Nimmi M Menon ◽  
Manjunath Adiga ◽  
Amritha E Pady
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
World Population ◽  
Sex Distribution ◽  
Aging Society ◽  
Ayurvedic Drugs ◽  
The World ◽  
The Individual ◽  
Treatment Aspect

Parkinson’s disease (PD) known as Kampavata in Ayurveda, is a degenerative neurological disorder of central nervous system, mainly affecting the motor system. It is the major cause of disability in the aging society, which usually affects after the age of 50 years. This disease is increasing in its frequency with the world population showing an incidence of 1-2 per 1000 population and has equal sex distribution. Symptoms like Kampa (Tremor), Stambha (Rigidity), Chestasanga (Bradykinesia and Akinesia), Vakvikriti (disturbance in speech) etc were described in different contexts of Charaka Samhita, Susruta Samhita and Basavarajeeyam. There is no cure for Parkinson’s disease, but medications, surgery and multidisciplinary management can provide relief and improve the quality of life of the individual. In the treatment aspect, the drug L-Dopa has shown better results similarly Ayurvedic drugs having the similar compounds are useful in this disorder. Based on the symptoms manifested, the disease can be correlated to Kampavata mentioned in Ayurveda classics. Despite of so many advances in the field of medicine, treatment of PD remains highly symptomatic. This instills the need for Ayurvedic management of Kampavata. The present article is intended to focus on the Nidana, Lakshanas, Samprapthi and the management principles of Parkinson’s disease (Kampavata).

THE FOOD INDUSTRY IN THE SEVENTIES1

1973 ◽  
Vol 36 (2) ◽  
pp. 71-75
Author(s):  
William O. Beers
Keyword(s):  
Crucial Role ◽  
Food Industry ◽  
Effective Means ◽  
World Population ◽  
Private Business ◽  
Social Purpose ◽  
The World ◽  
Zero Growth ◽  
The Individual

More than any other, the food industry is extensively and inextricably involved in the “growth/zero growth” or “quantity/quality” dilemma. For food, as man's own source of energy, is the determinative element in mankind's formula for survival. As the apparatus for supplying this source of energy, the food industry thus plays a crucial role in the resolution of the crisis that could eventually determine the fate of mankind. The food industry, both in regard to the individual consumer in the store, and the world population as a whole, will have to give even greater attention to the quality of its overall contribution in terms of the ends achieved by its products. Such a change in emphasis implies a greater degree of social purpose and accomplishment, but does not mean an erosion of the profit factor. For without profits, private business—the food industry included—cannot continue to function as the most effective means of allocating resources that man has yet developed.

Laser arytenoidectomy for bilateral vocal fold palsy in Parkinson's disease

2005 ◽  
Vol 119 (10) ◽  
pp. 831-833 ◽  
Author(s):  
A Qayyum ◽  
K Mierzwa ◽  
M See ◽  
A Sharma ◽  
P Q Montgommery
Keyword(s):  
Quality Of Life ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Treatment Option ◽  
Vocal Fold ◽  
English Literature ◽  
Vocal Fold Palsy ◽  
The Individual ◽  
Abductor Palsy

We report a case of laser arytenoidectomy for bilateral abductor palsy of the vocal fold in a patient with Parkinson's disease. Parkinson's disease is known to be a rare cause for bilateral vocal fold palsy and this is the second case reported in the English literature. Majority of the reports to date are in the non-English literature. Tracheostomy has been the classic treatment option offered to these patients. To date no report has been found in the literature about a laser arytenoidectomy being performed in a patient suffering from bilateral vocal fold palsy in Parkinson's disease. We have suggested this option as it improves the quality of life of the individual and avoids the difficulty faced by a Parkinson's patient in managing tracheostomy care due to bradykinesia, rigidity and tremor.

scholarly journals Prevención de la sarcopenia en pacientes con enfermedad de Parkinson: Revisión descriptiva desde la medicina preventiva

2021 ◽  
Vol 32 (1) ◽  
Author(s):  
Melissa Rodríguez-López ◽  
Jennifer Lucelly Sánchez-Tuyú ◽  
Nina Mendez-Dominguez
Keyword(s):  
Quality Of Life ◽  
Older Adults ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Primary Prevention ◽  
Preventive Medicine ◽  
Prevention Measures ◽  
Calidad De Vida ◽  
The World

Resumen: La enfermedad de Parkinson ocupa el segundo lugar de las enfermedades neurodegenerativas más comunes en el mundo. La sarcopenia se caracteriza por dinapenia y en los adultos mayores con diagnóstico de enfermedad de Parkinson acelera su progresión. El objetivo de la presente revisión es describir el estado sarcopénico y la importancia de su prevención en los adultos mayores con enfermedad de Parkinson, así como ofrecer una revisión de las medidas de prevención primaria, secundaria y terciaria pertinentes para su abordaje. Si bien  el deterioro y la gravedad de la enfermedad de Parkinson se relaciona directamente con el estado sarcopénico del paciente mediante el abordaje disciplinario, la medicina preventiva puede favorecer la calidad de vida de los pacientes mediante medidas de promoción, diagnóstico oportuno, tratamiento farmacológico y no farmacológico y limitación de la progresión de la sarcopenia.Abstract: Parkinson's disease ranks second among the most common neurodegenerative diseases in the world. Sarcopenia is characterized by dynapenia and in older adults diagnosed with Parkinson's disease accelerates its progression. The objective of the present review is to describe the sarcopenic state and the importance of its prevention in older adults with Parkinson's disease, as well as to offer a review of primary prevention measures, secondary and tertiary relevant to its approach. Although the deterioration and severity of Parkinson's disease is directly related to the sarcopenic state of the patient through the disciplinary approach, preventive medicine can favor the quality of life of patients through promotional measures, timely diagnosis, pharmacological treatment and not pharmacological and limiting the progression of sarcopenia.

scholarly journals Characterization of pain in patients with Parkinson’s disease: a descriptive cross-sectional study

2020 ◽  
Vol 9 (10) ◽  
pp. e6069109057
Author(s):  
Midia Wolff Marques ◽  
Andréia Fuentes dos Santos ◽  
Eduarda Carolina Amaral ◽  
Vivian Francielle França ◽  
Durcelina Schiavoni Bortoloti ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Joint Stiffness ◽  
Brief Pain Inventory ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Functional Changes ◽  
The Individual

Parkinson's disease affects the central nervous system, causing dysfunctional dopamine production. This directly affects the motor system, leading to the loss of voluntary movements, joint stiffness, limb tremors, and imbalance. Palliative treatments are applied to alleviate symptoms of the disease and improve quality of life. Considering functional changes and symptoms that are generated by Parkinson's disease, pain is also a debilitating factor that can severely affect the individual. The present study investigated the mean age, duration of involvement, body locus incidence, and interference with quality of life by pain in patients with Parkinson's disease. We applied a one-dimensional, subjective, and qualitative Visual Analog Scale and the multidimensional and interpretative Wisconsin Brief Pain Inventory. The study was conducted with 36 participants of both genders (mean age: 65.5 years for men and 72.0 years for women). The incidence of pain was detected in 87.5% of the participants. We found that pain occurred more frequently in the upper limbs and interfered with the performance of general activities. Treatment by a multidisciplinary team in all dimensions of the disease is needed to alleviate patients’ pain and consequently improve their quality of life.

scholarly journals Progression of Voice and Speech Impairment in the Course of Parkinson's Disease: A Longitudinal Study

2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
S. Skodda ◽  
W. Grönheit ◽  
N. Mancinelli ◽  
U. Schlegel
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Acoustic Analysis ◽  
Motor Impairment ◽  
Time Interval ◽  
Speech Impairment ◽  
Speech Performance ◽  
The Individual ◽  
Voice And Speech

Impairment of voice and speech occurs in the majority of patients in the course of Parkinson's disease (PD). The aim of the current study was to survey the changes of voice and speech performance in the individual patients over time. 80 patients with PD and 60 healthy speakers were tested and retested after at least 12 months (average time interval: 32.5 months). Participants had to read a given text which was digitally recorded as a source for the perceptual and acoustic analysis. Stage of the disease and global motor impairment were rated according to the accepted scales. As a result, abnormalities of voice and speech were already present in mildly affected patients and there were significant deteriorations of quality of voice and articulatory velocity and precision between baseline and followup examination which showed no correlation with the time interval between the visits. Summarized, voice, and speech performance were found to further deteriorate in the individual patient in the course of time although global motor impairment was widely stable which might be a hint for nondopaminergic mechanisms of progression of dysarthrophonia. Further investigations are warranted to get a better insight into the dynamics of the progression of voice and speech impairment in PD as a precondition for the development of therapeutic approaches.

Critical issues of the biopsychosocial treatment of Parkinson’s disease

2015 ◽  
Vol 156 (12) ◽  
pp. 472-478 ◽  
Author(s):  
Péter Kincses ◽  
Norbert Kovács ◽  
Kázmér Karádi ◽  
János Kállai
Keyword(s):  
Quality Of Life ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Psychological Health ◽  
Interdisciplinary Approach ◽  
Cognitive Status ◽  
Psychological Burden ◽  
Her Family ◽  
Critical Issues

This paper is a summary report on the basic questions of the biopsychosocial approach to Parkinson’s disease. It deals with cognitive, affective and psychological health issues which significantly influence the outcome of the physical rehabilitation. In spite of the unchanged cognitive status, the psychological burden of the changes in the quality of life, the obstruction, the change in the affective tone, and the shrinking ability to fulfil social roles decrease the patient’s quality of life. An interdisciplinary approach is best suited for mitigating these effects. Not only the patient but also his/her family and environment is seriously affected by the disease and its consequences. Treatment and rehabilitation options for increasing or maintaining the quality of life of the affected patients are diverse, and significantly depend on the features of the health care system. The authors believe that the following review emphasizing health psychological principles may contribute to the work of professionals working in clinical and rehabilitational fields and through them may increase the quality of life of patients and their family. Orv. Hetil., 2015, 156(12), 472–478.

scholarly journals The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers

2021 ◽  
pp. 1-15
Author(s):  
Eduardo Tolosa ◽  
Georg Ebersbach ◽  
Joaquim J. Ferreira ◽  
Olivier Rascol ◽  
Angelo Antonini ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Impact Assessment ◽  
Real World ◽  
European Countries ◽  
Life Questionnaire ◽  
Motor Symptoms ◽  
Non Motor Symptoms

Background: A greater understanding of the everyday experiences of people with Parkinson’s disease (PD) and their carers may help improve clinical practice. Objective: The Parkinson’s Real-world Impact assesSMent (PRISM) study evaluated medication use, health-related quality of life (HRQoL) and the use of healthcare resources by people with PD and their carers. Methods: PRISM is an observational cross-sectional study, in which people with PD and their carers completed an online survey using structured questionnaires, including the Parkinson’s Disease Quality of Life Questionnaire (PDQ-39), Non-Motor Symptoms Questionnaire (NMSQuest) and Zarit Burden Interview (ZBI). Results: Data were collected from 861 people with PD (mean age, 65.0 years; mean disease duration, 7.7 years) and 256 carers from six European countries. People with PD reported a large number of different co-morbidities, non-motor symptoms (mean NMSQuest score, 12.8), and impaired HRQoL (median PDQ-39 summary score, 29.1). Forty-five percent of people with PD reported at least one impulse control behaviour. Treatment patterns varied considerably between different European countries. Levodopa was taken in the last 12 months by 85.9% of participants, and as monotherapy by 21.8% . Carers, who were mostly female (64.8%) and the partner/spouse of the person with PD (82.1%), reported mild to moderate burden (mean ZBI total score, 26.6). Conclusions: The PRISM study sheds light on the lives of people with PD and those who care for them, re-emphasising the many challenges they face in everyday life. The study also provides insights into the current treatment of PD in Europe.

Effects of music-based movement therapy on motor function, balance, gait, mental health, and quality of life for patients with Parkinson’s disease: A systematic review and meta-analysis

2021 ◽  
pp. 026921552199052
Author(s):  
Zonglei Zhou ◽  
Ruzhen Zhou ◽  
Wen Wei ◽  
Rongsheng Luan ◽  
Kunpeng Li
Keyword(s):  
Quality Of Life ◽  
Mental Health ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Motor Function ◽  
Meta Analysis ◽  
Freezing Of Gait ◽  
Movement Therapy ◽  
Walking Velocity

Objective: To conduct a systematic review evaluating the effects of music-based movement therapy on motor function, balance, gait, mental health, and quality of life among individuals with Parkinson’s disease. Data sources: A systematic search of PubMed, Embase, Cochrane Library, Web of Science, PsycINFO, CINAHL, and Physiotherapy Evidence Database was carried out to identify eligible papers published up to December 10, 2020. Review methods: Literature selection, data extraction, and methodological quality assessment were independently performed by two investigators. Publication bias was determined by funnel plot and Egger’s regression test. “Trim and fill” analysis was performed to adjust any potential publication bias. Results: Seventeen studies involving 598 participants were included in this meta-analysis. Music-based movement therapy significantly improved motor function (Unified Parkinson’s Disease Rating Scale motor subscale, MD = −5.44, P = 0.002; Timed Up and Go Test, MD = −1.02, P = 0.001), balance (Berg Balance Scale, MD = 2.02, P < 0.001; Mini-Balance Evaluation Systems Test, MD = 2.95, P = 0.001), freezing of gait (MD = −2.35, P = 0.039), walking velocity (MD = 0.18, P < 0.001), and mental health (SMD = −0.38, P = 0.003). However, no significant effects were observed on gait cadence, stride length, and quality of life. Conclusion: The findings of this study show that music-based movement therapy is an effective treatment approach for improving motor function, balance, freezing of gait, walking velocity, and mental health for patients with Parkinson’s disease.

scholarly journals System models for resilience in gerontology: application to the COVID-19 pandemic

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Katarzyna Klasa ◽  
Stephanie Galaitsi ◽  
Andrew Wister ◽  
Igor Linkov
Keyword(s):  
The Elderly ◽  
System Level ◽  
Improve Quality ◽  
Care Needs ◽  
Individual Level ◽  
Chronic Stressors ◽  
The World ◽  
Aging Adults ◽  
The Individual

AbstractThe care needs for aging adults are increasing burdens on health systems around the world. Efforts minimizing risk to improve quality of life and aging have proven moderately successful, but acute shocks and chronic stressors to an individual’s systemic physical and cognitive functions may accelerate their inevitable degradations. A framework for resilience to the challenges associated with aging is required to complement on-going risk reduction policies, programs and interventions. Studies measuring resilience among the elderly at the individual level have not produced a standard methodology. Moreover, resilience measurements need to incorporate external structural and system-level factors that determine the resources that adults can access while recovering from aging-related adversities. We use the National Academies of Science conceptualization of resilience for natural disasters to frame resilience for aging adults. This enables development of a generalized theory of resilience for different individual and structural contexts and populations, including a specific application to the COVID-19 pandemic.

Sign in / Sign up

Export Citation Format

Share Document